TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · no major macro event
QURE

Uniqure NV

Healthcare · Biotechnology

22.50$ -2.6% vs. previous close Closing price · As of: Oct 8, 2026

Statements

Balance Sheet

Uniqure NV (QURE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 985 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet QURE
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
214 190 170 158 139 210 192 309 281 274 269 253 472 449 414 385 351 340 364 784 775 809 757 701 638 705 631 943 872 832 770 731 646 557 605 585 888 825 779 985
168 144 124 111 92 163 145 263 242 237 213 189 408 384 350 320 287 259 282 694 594 628 578 523 465 477 443 757 694 652 596 592 464 390 435 409 716 656 616 834
157 132 120 104 89 159 141 259 240 235 209 184 403 378 342 314 279 245 261 677 578 556 525 501 440 228 154 514 229 241 243 288 252 159 217 254 597 80 140 413
157 132 120 104 89 159 141 259 240 235 209 184 403 378 342 314 279 245 261 677 578 556 525 501 440 353 315 629 659 618 556 524 435 368 409 377 694 623 587 810
11 9.2 1.8 5.8 1.9 1.6 1.1 1.0 0.6 0.2 0.5 0.4 0.1 0.9 0.3 0.2 3.7 6.6 5.4 2.7 3.8 59 39 3.1 3.6 102 105 103 1.6 4.2 11 7.9 5.3 5.9 2.5 5.6 3.9 5.9 3.6 5.8
0.1 1.0 1.1 0.9 0.7 1.1 2.0 2.1 1.7 1.1 3.6 3.5 3.8 4.7 5.7 4.1 4.2 4.3 9.2 11 10 11 12 2.9 4.1 6.9 7.5 10 16 12 7.7 0.0 0.0 0.0 – – – – – –
33 36 35 35 35 34 34 32 31 29 28 28 28 29 28 29 30 32 34 65 67 44 45 74 48 83 50 49 76 – – – – – – – – – – –
0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 28 28 27 25 23 26 26 26 25 26 26 23 24 22 23 25 25 25 25 25
9.8 8.3 8.4 8.7 9.0 9.6 9.9 11 5.2 5.2 5.9 5.9 5.4 5.4 7.2 7.1 4.1 3.4 2.9 2.6 64 63 61 57 54 59 60 60 58 60 59 59 77 71 72 76 74 73 70 62
133 127 124 131 119 120 92 90 81 94 112 121 121 126 119 120 123 96 135 151 184 213 211 215 217 229 218 589 603 624 623 634 590 563 572 589 660 626 629 661
23 23 20 23 25 19 27 31 32 20 22 23 28 32 27 30 33 27 32 46 42 37 45 48 64 76 66 68 69 74 63 80 71 40 36 41 101 63 59 83
0.7 0.6 3.5 4.3 6.2 1.1 4.4 8.0 11 8.0 3.8 4.3 4.4 5.9 5.9 5.5 5.6 5.5 5.5 5.8 5.8 5.8 5.8 6.5 6.4 8.4 7.7 7.8 7.9 8.3 8.0 3.6 11 3.6 3.7 3.9 3.9 3.9 3.0 3.0
13 5.5 4.0 3.5 3.0 2.9 3.7 3.9 4.1 3.8 3.5 4.5 3.8 5.7 5.0 4.9 2.3 3.8 5.7 17 5.4 2.5 9.9 10 7.6 11 8.9 9.4 5.6 6.6 5.2 4.4 5.4 7.2 5.3 5.5 6.2 5.2 4.4 5.0
21 20 18 16 14 20 16 13 9.6 35 36 36 36 36 36 35 35 36 70 71 71 101 101 102 102 103 103 101 101 102 102 103 51 51 52 52 52 50 50 50
81 64 46 27 20 89 100 218 200 180 157 132 350 323 295 266 228 244 229 634 591 596 546 486 421 476 413 353 269 208 147 97 56 -6.8 34 -4.0 229 199 149 324
-343 -396 -416 -438 -448 -475 -471 -492 -514 -536 -563 -595 -618 -660 -688 -730 -784 -785 -826 -427 -463 -455 -502 -541 -589 -582 -659 -728 -817 -890 -956 -1,012 -1,057 -1,130 -1,174 -1,211 -1,292 -1,329 -1,382 -1,464
25 25 25 26 26 27 32 36 37 36 38 38 41 40 44 44 44 44 45 47 46 47 47 47 47 47 47 48 48 48 48 49 49 49 53 55 59 58 63 66

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?